Check out parts 1-3 on the trends poised to have the greatest impact on the market for life sciences data and evidence in 2022:
Part 1: Situational context and market dynamics
Part 2: Sources and uses of evidence
Part 3: Organizational impacts
-
FEATURED CONTENT
We’re only four months into 2022, and it’s clear the year ahead is going to be just as bumpy and unpredictable for life sciences organizations as 2021 was.
All signs point to a waning of the two-year-old COVID-19 pandemic, but there’s no shortage of new uncertainties impacting health care, global trade, and innovation.
Recently, life sciences market experts from Advisory Board and Optum Life Sciences came together to consider the trends poised to have the greatest impact on the market for life sciences data and evidence in 2022. Drawing on conversations with 200+ decision-makers across the health care ecosystem—as well as a series of executive roundtables and cross-industry events for life sciences medical, health economics and outcomes research (HEOR), and market access leaders—we identified 11 trends worth watching this year.
Situational context and market dynamics
- The coming wave of next-gen therapies
- Continued battles over drug pricing
- The pursuit of health equity
- Efforts to democratize clinical trials
Sources and uses of evidence
- Pushing beyond the tipping point for RWE
- Proliferating sources of real-world data (RWD)
- Anxiety over data privacy and security
- Harnessing the power of AI
- Expanding platforms for HCP’s consumption and circulation of evidence
Organizational impacts
- Evolving role of medical science liaisons
- Busting silos to maximize the ROI of RWD
Don't miss out on the latest Advisory Board insights
Create your free account to access 1 resource, including the latest research and webinars.
Want access without creating an account?
You have 1 free members-only resource remaining this month.
1 free members-only resources remaining
1 free members-only resources remaining
You've reached your limit of free insights
Become a member to access all of Advisory Board's resources, events, and experts
Never miss out on the latest innovative health care content tailored to you.
Benefits include:
Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox
You've reached your limit of free insights
Become a member to access all of Advisory Board's resources, events, and experts
Never miss out on the latest innovative health care content tailored to you.Benefits include:
Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox
